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Plumbago zeylanica is an effective medicinal plant and a potent herb for various diseases. The leaves of P. zeylanica 
were subjected to crude extraction using Ethyl acetate. Chromatographic analysis of the crude extracts of P. zeylanica were 
studied in thin layer chromatography on a silica gel matrix. Further the extracts were purified in column chromatography 
and the fractions were eluted in Ethyl acetate, Chloroform solvent system. The molecules eluted in the fractions were 
checked in UV-spectroscopy and further characterised by GC-MS analysis. Phenol, 2,4, bis (1,1-dimethyl ethyl)-(7311) 
highlighted from the chromatographic studies was studied for in silico anticancer effect on matrix metalloproteins, whose 
dysfunction cause oral squamous cell carcinoma.  
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In Ayurveda, Plumbago zeylanica is an effective 
medicinal plant and its parts are used for the treatment 
of asthma, gastrointestinal disorders, cough, jaundice, 
internal abscesses, urinary calculi, migraine, seminal 
weakness, insanity and vaginal discharge. It is also 
used as antiseptic, detoxicant and febrifuge. It is 
predominantly spread in Yemen, Oman and Saudi 
Arabia. The roots of P. zeylanica is effective in curing 
skin problems and has anti-inflammatory, anti-cancer, 
anti-diabetic and anti-hyperlipidemic property1-6. 
Primary metabolites are primary products of the 
plants, such as proteins, lipids, heme, chlorophyll, 
carbohydrates and nucleic acids, which are involved 
to maintain plant cells through the primary metabolic 
process. Secondary metabolites are products of the 
plants such as chemicals, which will not participate in 
biochemical reactions and maintaining plant cells, but 
plays a shielding role against pathogens7. Secondary 
metabolites extracted from plants are more effective 
and acts as an efficient drug for various diseases8. 
Their action is similar to ligands, hormones,  
signal transduction molecules, neurotransmitters, 
endogenous metabolites and its therapeutic efficacy in 
humans is based on their respective target sites9.  
The study of structural similarity between the 
secondary metabolites and endogenous substances of 
particular organisms is called progressive molecular 
modelling10. Secondary metabolites protect plants 
against biotic (bacteria, fungi, nematodes, insects or 
grazing by animals) and abiotic (higher temperature 
and moisture, shading, injury or presence of heavy 
metals) stresses. They are divided into three 
chemically distinct groups - Terpenes, Phenolics, N 
(Nitrogen) and S (sulphur) containing compounds11. 
Oral squamous cell carcinoma (OSCC), is a 
primary malignancy arising in the neck and head. 
Nearly 500,000 new cases are recorded each year12. In 
Taiwan, it is fourth popular male cancer13 because of 
the use of alcohol and tobacco14,15. In the early stage, 
the treatment option for OSCC is a surgical operation, 
but intermediate and advanced stage treatment 
involves radiotherapy and chemotherapy along  
with standard treatments16. The gene matrix 
metalloproteinase-2 (MMPs2) has been expressed in 
the tissues of gastric cancer relative to the matched 
normal tissues associated with gastric cancer cells 








dysregulated in Ovarian cancers and are seen as 
possible biomarkers18. 
Expression and involvement of matrix 
metalloproteinase (MMPs) in oral squamous cell 
carcinomas, have been studied by many authors19,20. 
The matrix metalloproteinase (MMPs) are responsible 
for degradation of tissues in both normal and 
pathological conditions such as tumour invasion and 
metastasis whereas metalloproteinase tissue inhibit 
ors (TIMPs) decrease the function of those MMPs. 
Therefore, MMPs can directly or indirectly mediate the 
angiogenic response by modulating the balance 
between pro-and antiangiogenic factors21. Matrix 
metalloproteinases (MMPs) are proteolytic enzymes of 
a secretary or membrane type that operate on 
extracellular protein components such as collagen, 
gelatin, elastin, laminin, fibronectin, and integrin. 
MMPs are synthesized as zymogens, and activated  
by autoproteolysis or other proteases to functional 
forms22. They are involved in trophoblast implantation, 
embryogenesis, bone growth, angiogenesis, wound 
healing, and tissue regeneration. So far 24 MMPs are 
identified in vertebrates, including 23 in humans23. 
They are endopeptidases and their enzymatic activity is 
determined by Ca2+ and Zn2+ ions24. 
In Oral squamous cell carcinoma, function and 
regulation of MMPs are not proper. Dysfunctional 
MMPs is one of the initiators of Oral squamous cell 
carcinoma. All types of MMPs consist of propeptide 
domain, which is an inactive enzyme, followed by 
catalytic domain which has the zinc active site 
attached to methionine and three histidine residues 
and the hemopexin (3c7x) is one of the c-terminal 
domain. The C-terminal domain bind with inhibitors 
and substrate specifically. The extracellular MMPs 
are activated by the integrins or proprotein 
convertases which are present in the cell. Proprotein 
convertases break the prodomain from the catalytic 
domain, which activates MMPs25. The abnormal 
production of normal tissue and activity of various 
MMPs causes several cancers. 
The aim of the study is to screen the active 
metabolites from the crude leaf extracts of  
P. zeylanica by thin layer chromatography. Column 
chromatography was performed for the plant extracts 
and the eluted fractions was analysed for the presence 
of organic molecules by studying their absorption 
profile when subjected in the electromagnetic 
spectrum on a UV spectroscopy. The fractions that 
had similar resonance which reflected in their 
absorbance was pooled together and further 
characterized by GC-MS analysis. Six compounds 
were present in high amounts (more than 10 %) - (i) 
9-Eicosene, (ii) Phenol, 2,4-bis(1,1-dimethylethyl), 
(iii) Pentadecane, (iv) M-Cymene, 5-tert-butyl,  
(v) Benzene, 1,3-bis(1,1-dimethylethyl), (vi) 9-
Octadecene. These 6 compounds were tested for its 
anticancer (Oral squamous cell carcinoma) property 
by in silico method. 
 
Materials and Methods 
Preparation of plant extract 
Ethyl acetate solvent (200 mL) was added to 100 g 
of the leaf of P. zeylanica and placed on an orbital 
shaker for 48 h at room temperature. The filtrate was 
collected and the extract was concentrated to 
evaporate the solvent by rotary evaporator at low 
temperature (70C) under medium pressure condition. 
The dried crude extract was collected and stored. 
 
Characterization by thin layer chromatography method 
The crude extract was spotted on pre-coated TLC 
silica plates and allowed to dry. Silica sheet was 
placed into a beaker containing different solvent 
systems such as Hexane, chloroform, ethyl acetate 
and methanol. Solvents used were - (i) Hexane: 
Chloroform in the ratio of 100: 0, 90: 10, 80: 20, 70: 
30, 60: 40, 50: 50, 40: 60, 30:70, 20: 80, 10: 90 (ii) 
Chloroform: Ethyl acetate in the ratio of 100: 0, 90: 
10, 80: 20, 70: 30, 60: 40, 50: 50, 40: 60, 30: 70, 20: 
80, 10:90 and (iii) Ethyl acetate: Methanol in the ratio 
of 100: 0, 90: 10, 80: 20, 70: 30, 60: 40, Sol.50: 50, 
40: 60, 30: 70, 20: 80, 10: 90. Visible band identified 







Characterization by Column chromatography method: 
The Slurry was prepared using 8 g of silica gel  
(60-120 mesh) with chloroform and it was poured into 
the 50 cm column. The column was pre-run three 
times using chloroform to settle the silica without  
air bubbles and 10 g of ethyl acetate extract of  
P. zeylanica was placed on the column. The solvent 
system Chloroform: ethyl acetate (1:1) gave better 
elution and resolution when checked in a thin layer 
chromatography. 
 
Characterization by UV-Spectroscopy method 
UV-Visible spectroscopy was used to qualitatively 
identify the presence of molecules in a biological 




mixture which resonate in the UV visible region. 
Natural plant compound that was identified by  
UV-Visible spectroscopy are many and they are,  
280 nm for phenolic extract, 360 nm for phenolic 
acids, 320nm for flavones etc27. Visible range from 
200 to 800 nm was selected to identify various 
compounds present in the fraction. UV - spectroscopy 
instrument Shimadzu UV-1800, Japan was used  
for the study. 
 
Characterization by GC-MS analysis 
Gas chromatograph 
Shimdzu GC-2010 Plus gas chromatograph 
consisted of 2 mm direct injector and 15 M Alltech 
EC-5 column (250 µM I.D., 0.25 µM film thickness). 
The split injector was used to introduce the sample in 
two columns and the split was fixed 10:1. The oven 
temperature was set at 35C for 2 min and helium act 
as the carrier gas for 2 mL per min. 
 
Mass spectrum 
A Direct connection with capillary column metal 
quadruple mass filter period mass spectrometer 
operating in electron ionization (EI) mode with a 
software GC-MS solution Ver. 2.6 was used for all 
analysis. Low-range mass spectra were identified at a 
resolving power of 1000 (20% height definition) and 
scanning from m/z 25 to m/z 1000 at 0.3 sec per scan 
with a 0.2 sec inter-scan delay. High range mass 
spectra were determined at a resolving power of 5000 
(20% height definition) and scanning the magnet from 
m/z 65 to m/z 1000 at 1 sec per scan. 
 
Protein and ligand structure retrieval and docking 
The structure of the phytochemicals - 9-Eicosene 
(5365037), Phenol, 2, 4-bis (1,1-dimethylethy l) 
(7311), Pentadecane (12391), m-Cymene, 5-tert-butyl 
(34640), Benzene, 1,3-bis (1,1-dimethylethyl) 
(136810), 9-Octadecene (5364599) - was retrieved 
from the PubChem database in ‘sdf’ format. 
Consecutively the three-dimensional structure of two 
anticancer drugs, namely Doxycyclin and 
Fluorouracil (5-FU) were also downloaded in order to 
carry out a comparative analysis of their efficiency 
against the phytochemicals of our interest. Similarly, 
the three-dimensional structure of the hemopexin 
domain of protein Matrix metallopeptidase (PDB ID: 
3C7X)28 with196 amino acids in length was also 
downloaded in ‘.pdb’ format from the Protein Data 
Bank (PDB)29. Its resolution was 1.70 A and was 
determined by the X-Ray diffraction method. The 
quality of the structure was analyzed using the 
Ramachandran plot30. The target is prepared by 
applying CHARMM force field31 to add required 
hydrogen bonds. The binding site of the target was 
determined and docking was carried out using 
Discovery studio based on Ligand Fit protocol32 for 




Crude extracts from the leaf of P. zeylanica was 
extracted using ethyl acetate. Plant metabolites were 
screened by Thin layer chromatography and it was 
partially purified through column chromatography. 
The UV-spectroscopy was used to find the presence 
of organic molecules and those with similar 
absorption profile was polled to a single fractions 
which was then characterized by GC-MS. Compounds 
whose concentration were more than 10 % in GC-MS 
was tested for anticancer activity by in silico model to 
inhibit MMPs.  
 
Thin layer chromatography 
30 solvent systems in various combinations of four 
solvents in different ratios were used to evaluate the 
crude leaf extract of P. zeylanica on a TLC plate. 
Four clear bands were obtained on the TLC plate for 
solvent combination Chloroform 50%: Ethyl acetate 
50%, having corresponding Rf values as follow 3.6, 
3.8, 2 and 3.4 (Fig. 1A). No bands were obtained for 
other solvent combinations, i.e Hexane: Chloroform 
and Ethyl acetate: Methanol (Fig. 1B). 
 
Column chromatography 
Chloroform: Ethyl acetate (50%: 50%) was poured 
into the column as a mobile phase to collect  
45 fractions of 2 mL quantity. Fraction 1-10- was 
dark green in colour, fraction 11-20-dark green to 
light green colour, fraction 21-30-light green colour, 
fraction 31-45-yellow colour (Fig. 2). 
 
UV-visible spectroscopy 
The collected fraction was analyzed by UV range 
200 to 800 nm to find out similarity based on the 
concentration. After recognizing the peak value of the 
fractions, it was pooled. Fraction 1-10 was described 
as sample 1, fraction 11-20 was described as sample 2 
, fraction 21-30 was denoted as sample 3, and fraction 
31-45 represented as sample 4 (Fig. 3)  
 
GC-MS analysis 
Samples 1, 2, 3 and 4 were analyzed by GC-MS to 
detect the name of the secondary metabolite according  
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Fig. 2 — 16th fraction & 16th solvent system
acetate, 50:50) 
 
to the wavelength. Visible range differs depending on 
functional group Sample 1 consisted of 19 bioactive 
compounds (Fig. 4 & Table 1), Sample 2 contained 
15 bioactive compounds (Fig. 4 & Table 2), Sample 3 
contained 10 secondary metabolites (Fig. 4 & 
Table 3), Sample 4 consisted of 14 secondary 











Binding site determination and molecular docking
Grid points in the target structure were mapped and 
from it, the binding sites found in the target was 
determined. Among the three binding sites, site 1 is 
the largest with 462 points and 57.750A0^3 in size. 
Site 2 is with 188 points and 23.500 A0^3 follow
by the smallest site 3 of 120 points and 15.000 A0^3 
sizes. ADMET properties of the ligands were 
screened to test the efficiency of the compound to be 
used as a drug. The molecular docking analysis of the 
ligand with the target was carried out and analy
which revealed the possible confirmation created by 
each ligand inside the binding site of the target. The 
binding affinity of each ligand with the target was 
calculated based on the comparison of all the different 
binding scores and are represented in
along with the name of the ligand. 
 
Intermolecular interaction of the target and ligand
The intermolecular interaction of the ligand with 
the target was analyzed to determine the type of bond 
occurring between them and their distance. Table 6 
gives details about the intermolecular interactions 
occurred between the atoms in the target along wi
the atoms of the ligand. Figures 1 to 3 shows the two 
dimensional and three-dimensional representation of 
the intermolecular interaction of each ligand with the 
amino acids in the target.  

















Fig. 3 — Sample 1- (fraction-1 to 10); Sample 2- (fraction-11 to 20); Sample 3- (fraction-21 to 30); and Sample 4- (fraction-31 to 45)  
(Contd.) 
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Fig. 3 — Sample 1- (fraction-1 to 10); Sample 2
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- (fraction-11 to 20); Sample 3- (fraction-21 to 30); and Sample 4
Fig. 4 — Samples 1-4 GC-MS (Contd.) 
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- (fraction-31 to 45) 
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Discussion 
The alcoholic extract from Plumbago zeylanica
roots was tested against clinically resistant multidrugs 
(Salmonella paratyphi, Staphylococcus 
Escherichia coli and the dysenteriae Shigella
The extract has shown good antibacterial activity 









only ethyl acetate extract exhibit the antibacterial 
(Salmonella paratyphi, Staphylococcus aur
Escherichia coli) and antioxidant activity compare to 
other solvent (Hexane, Chloroform and Methanol) 
extracts34,35. Hence Ethyl acetate extract used to 
isolate secondary metabolites
bioactivity by in silico method  
 
eus, 
36 and found the 




Table 1 — Bioactive compounds present in sample 1 
S. No Name of The Compounds Rt. Time % High 
Value 
1. 2-Butanone, 4-hydroxy- 5.064 3.02 
2. Benzene, 1,3-bis(1,1-dimethylethyl)- 5.703 10.03 
3. Nonane, 5-(2-methylpropyl 5.892 2.21 
4. Tetradecanal 7.374 7.81 
5. Sulfurous acid, 2-ethylhexyl  
isohexyl ester 
8.539 4.00 
6. Phenol, 2,4-bis(1,1-dimethylethyl) 8.875 11.64 
7. Undecane, 3,8-dimethyl 9.232 3.28 
8. Hydrazine, tetraphenyl 10.966 1.22 
9. Nonane, 3,7-dimethyl 12.207 1.34 
10. Nonane, 5-methyl-5-propyl 13.415 3.30 
11. Hexadecane, 1-iodo 17.593 3.99 
12. 7,9-Di-tert-butyl-1-oxaspiro(4,5)deca 17.593 3.96 
13.  5-methyl-5-propyl 18.700 3.35 
14. Undecane, 2,9-dimethyl 18.842 0.92 
15. 9-Eicosene, (E)- 19.434 12.03 
16. Heptadecane, 2,6,10,15-tetramethyl 19.593 6.20 
17. 1-Fluorononane 23.805 1.68 
18. Bromododecane 24.982 2.55 
19. Nonadecanol-1 30.136 4.83 
 
 
Table 2 — Bioactive compounds present in sample 2 
S. No Name of The Compounds Rt. Time % High 
Value 
1. Octane, 6-ethyl-2-methyl 5.071 2.35 
2. Oxalic acid, isohexylneopentyl ester 5.892 2.37 
3. Decyltrifluoroacetate 7.125 5.90 
4. 1-Hexene, 3-methyl 8.300 0.58 
5. 9-Octadecene 8.300 12.91 
6. Cyclohexane, (1-butylhexadecyl) 10.549 0.92 
7. Propanoic acid, 2,2-dimethyl-,  
2,6-bis(1,1-dimethylethyl)- 
17.708 1.69 
8. Heptadecane, 19.607 5.99 
9. Bromotetradecane 23.279 0.66 
10. Pentadecyltrifluoroacetate 24.839 9.10 
11. 1-Heneicosanol 30.139 5.51 
12. Borane, diethyl(decyloxy) 30.267 1.04 
13. Cyclotetracosane 36.618 1.51 
14. n-Tetracosanol 43.267 1.98 
15. Nonadecylpentafluoropropionate 45.518 1.25 
 
MMPs induces cancer progression and invasion 
leading to the death of the patient37,38. Reported the 
induction of tumour angiogenesis by MMPs as they 
first digest the extracellular matrix (ECM) and then 
penetrating into the basement membrane for invading 
the adjacent tissues and vessels thus involving  
in   metastasis.   As  MMPs  play   a  vital  role  in  the  
Table 3 — Bioactive compounds present in sample 3 
S.No Name of The Compounds Rt. Time % High 
Value 
1. m-Cymene, 5-tert-butyl 5.712 9.70 
2. Nonane, 5-(2-methylpropyl) 5.892 2.41 
3. 1-Undecanol 7.120 5.81 
4. Pentadecane 7.211 11.74 
5. Z-4-Dodecenol 7.384 2.20 
6. 1-Iodoundecane 9.730 1.03 
7. 1-Decene, 8-methyl 10.545 0.87 
8. Octane, 3,6-dimethyl 13.804 1.12 
9. 2,2,6,6-Tetramethylheptane 18.850 0.70 
10. Cyclodocosane, ethyl 36.619 1.73 
 
 
Table 4 — Bioactive compounds present in sample 4 
S.No Name of The Compounds Rt. Time % High 
Value 
1. Octane, 2,7-dimethyl 5.062 2.03 
2. Decane, 2,3,7-trimethyl 5.892 2.39 
3. Pentadecanal 7.385 1.87 
4. 5-Methyl-1-heptanol 8.283 0.58 
5. Hexane, 2,4,4-trimethyl 9.417 0.60 
6. Decane, 3,8-dimethyl 9.732 0.99 
7. 3,5-Dimethyl-4-octanone 9.968 0.46 
8. Hexadecanal 10.544 0.81 
9. 10-Dimethyl-4-undecanol 27.626 0.63 
10. Hexane, 2,4,4-trimethyl 30.000 0.40 
11. Heptadecyltrifluoroacetate 36.608 1.60 
12. 1-Heptacosanol 43.265 1.82 
13. Decanedioic acid, bis(2-ethylhexyl) 43.488 1.16 
14. Tetracosyltrifluoroacetate 45.517 1.10 
 
progression of cancer, the research involved in 
finding out MMP inhibitors (MMPIs) are on the rise 
and resulted in the identification of drugs like 
Batimastat, Marimastat, Prinomastat, CGS27023A, 
Tanomastat and Doxycycline.Clinical trials were 
stopped for all the above drugs for showing toxicity in 
patients except for doxycycline39,40. Scatena C 
reported that treatment of breast cancer patients with 
doxycycline selectively eradicated cancer stem cells.  
As an anti-infectious agent against life threatening 
disease causing species, bioactive metabolites from 
conventional plant extracts41. Secondary metabolites 
isolated from our study showed a higher docking 
score compared to doxycycline. Hence it became 
evident that these compounds can outperform the 
efficacy of doxycycline in inhibiting MMPs. Among 
the six different secondary metabolites studied, 9-
Octadecene (5364599) (Fig. 5F) had a better docking 
score  followed  by 9- Eicosene  (5365037)  (Fig. 5A).  





Table 5 — The name of each phytochemical along with their docking scores in comparison with the already available  
drugs for treating OSCC 
S. No Name of compound Ligand Score 1 Ligand Score 2 PLP1 PLP2 Jain Dock Score 
1 9-EICOSENE −999.9 -999.9 68.65 70.36 2.47 70.907 
2 PHENOL, 2,4,BIS(1,1-DIMETHYL ETHYL) 1.43 2.85 58.25 65.01 4.71 53.775 
3 PENTADECANE 0.24 1.7 66 73.49 6.71 66.657 
4 M-CYMENE-5-TERT-BUTYL −999.9 -999.9 55.85 61.19 3.38 63.662 
5 BENZENE,1,3 BIS (1,1-DIMETHYL ETHYL) 0.58 2.63 50.32 55.13 3.74 49.714 
6 9-OCTADECENE −999.9 -999.9 65.26 69.55 3.72 71.325 
7 5-FU 3.38 3.38 55.69 41.63 2.47 49.982 
8 Doxycyclin 2.7 3.04 46.98 57.38 4.58 30.729 
 
 
Table 6 — The intermolecular interaction of the atoms in ligand with the atoms of the target in the binding site 
S. No Ligand ID Interacting atom Distance 
Category of 
interaction 





















7311:C2 - A:MET422 4.78242 Hydrophobic Alkyl 
7311:C3 - A:MET422 5.20223 Hydrophobic Alkyl 
A:PHE420 - 7311:C2 5.05847 Hydrophobic Pi Alkyl 
7311 - A:MET422 4.8037 Hydrophobic Pi Alkyl 
7311:H37 - 
A:GLU373:OE1 
1.91303 Hydrogen Bond 
Conventional 
Hydrogen 
7311:C2 - A:MET422 4.78242 Hydrophobic Alkyl 
7311:C3 - A:MET422 5.20223 Hydrophobic Alkyl 
A:PHE420 - 7311:C2 5.05847 Hydrophobic Pi Alkyl 








































4.57784 Hydrophobic Pi Alkyl 
34640 - A:MET422 4.63574 Hydrophobic Pi Alkyl 
34640:C14 - 




4.57784 Hydrophobic Pi Alkyl 







4.85695 Hydrophobic Alkyl 
NIL 
136810 - A:MET328 5.35882 Hydrophobic Pi Alkyl 






3.85894 Hydrophobic Alkyl NIL 
JENIFER et al.: INSIGHTS FROM THE AN
 
 
Fig. 5 — Intermolecular interaction of (A) 9
(12391); (D) M-Cymene-5 tert butyl (34640); (E) Benzene,1,3 bis (1,1 dimethyl ethyl)
the target protein Hemopexin (HPX) -3c7x 
 
Though the docking score was more of these two, the 
number of interactions occurred between them with 
the target was less when compared to the remaining 
four ligands.  
Phenol, 2,4, bis (1,1-dimethyl ethyl)
predominates in intermolecular interaction as it shared 
ten different bonds with the target (Fig. 5B). This 
includes two hydrogen bonds with the amino acids 
methionine at the 422 positions and the glutamine at 
373 positions of the target, the remaining bonds were 
alkyl bonds. The compound phenol
dimethylethyl), is a precursor to many complex 
compounds and commonly used for the synthesis of 
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-Eicosene (5365037); (B) Phenol,2,4,bis (1,1-dimethylethyl)
-(136810); and (F) 9-Octadecene (5364599) with 
-(7311) 
-2, 4-bis (1,1-
other chemical intermediates as antioxidants, light 
control agents or UV stabilisers. Though phenol
bis (1, 1-dimethylethyl) could be achieved as the 
natural antimicrobial compound from plant 
materials42,43, animal materials44,45
metabolites such as Streptomyces
algae47 and Pseudomonas monteilii
sp.49, Bacillus velezensis50, Vibrio alginolyticus
Vibrio owensii52, Vibrio sp.53
Microbacterium mangrove, Sinomonas humi and 
Monashia flava55 etc. Also Phenol
dimethylethyl) was an antifungal compound of 
Pseudomonas fluorescens TL in nature
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-(7311); (C) Pentadecane 
-2,4-
. And microorganism 
 sp.46, Shewanella 
48, Nocardiopsis 
51, 
, Bacillus subtilis54, 
-2, 4—bis (1, 1-
56. 




Pentadecane (12391) (Fig. 5C) and M-Cymene-5 
tert- butyl (34640) (Fig. 5D) shared six bonds each 
with the binding site of the target, while Benzene1,3 
bis (1,1 dimethyl ethyl)-(136810) (Fig. 5E) shared 
only three bonds. All the compounds passed ADMET 
test and hence can be considered as promising agents 
to be used as a drug for further testing and treatment. 
 
Conclusion 
Thus the study concluded that Phenol, 2,4, bis (1,1-
dimethylethyl)-(7311) showed better interaction with 
MMPs and it can probable drug candidate for treating 
oral carcinoma. It should be further evaluated in vivo 
preclinical and clinical studies. Admit descriptors 
were satisfactory.  
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